Polypharmacy and malnutrition

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 16, Issue 1, 2013, Pages 50-55

  Zadak, Zdenek ^a   Hyspler, Radomir ^a   Ticha, Alena ^a   Vlcek, Jiri ^b  

^a UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

drugs; malnutrition; nutritional status; polypharmacy

Indexed keywords

COMORBIDITY; CZECH REPUBLIC; DRUG EFFECT; FINLAND; FOOD INTAKE; HOSPITAL PATIENT; HUMAN; MALNUTRITION; NETHERLANDS; NORWAY; NUTRITIONAL STATUS; OUTPATIENT; POLYPHARMACY; REVIEW;

AGED; CZECH REPUBLIC; ELDER NUTRITIONAL PHYSIOLOGICAL PHENOMENA; FINLAND; HUMANS; MALNUTRITION; NETHERLANDS; NORWAY; NUTRITION ASSESSMENT; NUTRITIONAL STATUS; OUTPATIENTS; POLYPHARMACY; PREVALENCE; RISK FACTORS;

EID: 84871919101     PISSN: 13631950     EISSN: 14736519     Source Type: Journal    
DOI: 10.1097/MCO.0b013e32835b612e     Document Type: Review

References (17)

1. Fialová D, Topinková E, Gambassi G, et al. Potentially inappropriate medicationuse among elderly home care patients in Europe. JAMA 2005; 16:1348-1358 (Pubitemid 40381487)
2. Jyrkkä J, Mursu J, Enlund H, et al. Polypharmacy and nutritional status in elderlypeople. Curr Opin Clin Nutr Metab Care 2012; 15:1-6
3. Jyrkkä J, Enlund H, Lavikainen P, et al. Association of polypharmacy withnutritional status, functional ability and cognitive capacity over a free-year periodin an elderly population. Pharmacoepidemiol Drug Saf 2011; 20:514-522
4. Heuberger RA, Caudell K. Polypharmacy and nutritional status in older adults.A cross-sectional study. Drugs Aging 2011; 28:315-323
5. Vanderwee K, Clays E, Bocquaert I, et al. Malnutrition and associated factorsin elderly hospital patients: a Belgian cross-sectional, multicentre study. ClinNutr 2010; 29:469-476
6. Elia M. Quantitative biology and nutritional support. Clin Nutr 2003; 22 (Suppl2):S33-S35
7. Vellas B, Villars H, Abellan G, et al. Overview of the MNA-its history andchallenges. J Nutr Health Aging 2006; 10:456-465
8. Veehof LJG, Stewart RE, Haaijer-Ruskamp FM, et al. The development ofpolypharmacy. A longitudinal study. Fam Pract 2000; 17:261-267
9. Werder SF, Preskorn SH. Managing polypharmacy: walking the fine linebetween help and harm. Curr Psychiatry 2003; 2:24-36
10. Franssen FME, Spruit MA, Wouters EFM. Determinants of polypharmacy andcompliance with GOLD guidelines in patients with chronic obstructivepulmonary disease. Int J COPD 2011; 6:493-501
11. Rambhade S, Chakarborty A, Shrivastava A, et al. A survey on polypharmacyand use of inappropriate medications. Toxicol Int 2012; 19:68-73
12. Moss L, Crane PB. Exploring polypharmacy in elderly women after myocardialinfarction. J Women Aging 2010; 22:22-33
13. Sergi G, De Rui M, Sarti S, et al. Polypharmacy in the elderly: can comprehensivegeriatric assessment reduce inappropriate medication use? DrugsAging 2011; 28:509-518
14. Runciman WB, Roughead EE, Semple SJ, et al. Adverse drug events andmedication errors in Australia. Int J Qual Health Care 2003; 15 (Suppl 1):i49-i59 (Pubitemid 37536825)
15. Lisby M, Nielsen LP, Mainz J. Errors in the medication process: frequency,type, and potential. Int J Qual Health Care 2005; 17:15-22 (Pubitemid 40260139)
16. Bytzer P. Dyspepsia as an adverse effect of drugs. Best Pract Res ClinGastroenterol 2010; 24:109-120
17. Sampson G. Weight loss and malnutrition in the elderly. Aust Fam Phys 2009;38:507-510